Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features

Oncology Reports

Volumn 11, Issue 2, 2004, Pages 341-348

  Lin, Shyr Yi ^a,b   Yeh, Kun Tu ^c   Chen, Willian Tzu Liang ^c   Chen, Hung Chang ^c   Chen, Shou Tung ^c   Chiou, Hung Yi ^b   Chang, Jan Gowth ^d  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Direct sequencing; Immunohistochemistry; Methylation specific PCR; Multiple methylation phenotype; Tumor suppressor genes

Indexed keywords

CYTIDYLYL 3' 5' GUANOSINE; CYTIDYLYL-3'-5'-GUANOSINE; DINUCLEOSIDE PHOSPHATE; PRIMER DNA;

ARTICLE; COLON; COLON TUMOR; COLORECTAL TUMOR; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; COLON; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DINUCLEOSIDE PHOSPHATES; DNA METHYLATION; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS);

EID: 3242749984     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.2.341     Document Type: Article

References (38)

1. Holliday R and Grigg GW: DNA methylation and mutation. Mutat Res 285: 61-67, 1993. (Pubitemid 23029555)
2. Singer-Sam J, Goldstein L, Dai A, Gartler SM and Riggs AD: A potentially critical Hpall site of the X chromosome-linked PGK1 gene is unmethylated prior to the onset of meiosis of human oogenic cells. Proc Natl Acad Sci USA 89: 1413-1417, 1992.
3. Barlow DP: Gametic imprinting in mammals. Science 270: 1610-1613, 1995.
4. Li E, Bestor TH and Jaenisch R: Targeted mutation of the DNA methyl-transferase gene results in embryonic lethality. Cell 69: 915-926, 1992.
5. Antequera F, Boyes J and Bird A: High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 62: 503-514, 1990.
6. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM and Baylin SB: Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91: 9700-9704, 1994. (Pubitemid 24311875)
7. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D: 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1: 686-692, 1995.
8. Funayama N, Fagotto F, McCrea P and Gumbiner BM: Embryonic axis induction by the armadillo repeat domain of beta-catenin: evidence for intracellular signaling. J Cell Biol 128: 959-968, 1995.
9. Cadigan KM and Nusse R: Wnt signaling: a common theme in animal development. Genes Dev 11: 3286-3305, 1997. (Pubitemid 28023954)
10. Arias AM, Brown AM and Brennan K: Wnt signalling: pathway or network? Curr Opin Genet Dev 9: 447-454, 1999. (Pubitemid 29385343)
11. Polakis P: Wnt signling and cancer. Genes Dev 14: 1837-1851, 2000.
12. Kolligs FT, Bommer G and Goke B: Wnt/beta-catenin/Tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion 66: 131-148, 2002.
13. Berx G, Cleton-Jansen AM, Nollet F, De Leeuw WJ, van de Vijver M, Cornelisse C and van Roy F: E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancer. EMBO J 14: 6107-6115, 1995. (Pubitemid 26007298)
14. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A and Reeve AE: E-cadherin germline mutations in familial gastric cancer. Nature 392: 402-405, 1998. (Pubitemid 28168738)
15. Barth AL, Nathke IS and Nelson WJ: Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Curr Opin Cell Biol 9: 683-690, 1997. (Pubitemid 27424925)
16. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S and Yoshimura A: A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387: 921-924, 1997. (Pubitemid 27289595)
17. Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE, Harris CC and Herman JG: SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 28: 29-35, 2001. (Pubitemid 32405812)
18. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JJ, Davidson NE, Sidransky D and Baylin SB: Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancer. Cancer Res 55: 4525-4530, 1995.
19. Herman JG, Jen J, Merlo A and Baylin SB: Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res 56: 722-727, 1996.
20. Pisani P, Parkin DM, Bray F and Ferlay J: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83: 18-29, 1999. (Pubitemid 29409471)
21. Bienz M and Clevers H: Linking colorectal cancer to Wnt signaling. Cell 103: 311-320, 2000.
22. Fodde R, Smits R and Clevers H: APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 1: 55-67, 2001. (Pubitemid 33741881)
23. Su TH, Wang JC, Tseng HH, Chang CP, Chang TA, Wei HJ and Chang JG: Analysis of FHIT transcripts in cervical and endometrial cancers. Int J Cancer 76: 216-222, 1998.
24. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996. (Pubitemid 26296693)
25. Lee WS, Chen RJ, Wang YJ, Tseng H, Jeng JH, Lin SY, Liang YC, Chen CH, Lin CH, Lin JK, Ho PY, Chu JS, Ho WL, Chen LC and Ho YS: In vitro and in vivo studies of the anticancer action of terbinafine in human cancer cell lines: G0/G1 p53-associated cell cycle arrest. Int J Cancer (In press).
26. Shen L, Toyota M, Kondo Y, Obata T, Daniel S, Pierce S, Imai K, Kantarjian HM, Issa JP and Garcia-Manero G: Aberrant DNA methylation of p57KIP2 identifies a cell cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia. Blood 101: 4131-4136, 2003. (Pubitemid 36857895)
27. Nagai H, Kim YS, Lee KT, Chu MY, Konishi N, Fujimoto J, Baba M, Matsubara K and Emi M: Inactivation of SSI-1, a JAK/STAT inhibitor, in human hepatocellular carcinomas, as revealed by two-dimensional electrophoresis. J Hepatol 34: 416-421, 2001. (Pubitemid 32240821)
28. Galm O, Yoshikawa H, Esteller M, Osieka R and Herman JG: SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood 101: 2784-2788, 2003.
29. Minamoto S, Ikegame K, Ueno K, Narazaki M, Naka T, Yamamoto H, Matsumoto T, Saito H, Hosoe S and Kishimoto T: Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3. Biochem Biophys Res Commun 237: 79-83, 1997. (Pubitemid 27390327)
30. Serrano M, Hannon GJ and Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707, 1993. (Pubitemid 24036021)
31. Hannon GJ and Beach D: p15INK4B is a potential effector of TGF-β-induced cell cycle. Nature 371: 257-261, 1994.
32. Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, Nakatsuru S, Aoki T, Miki Y, Mori T and Nakamura Y: Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1: 229-233, 1992.
33. Esteller M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Gonzalez S, Tarafa G, Sidransky D, Meltzer SJ, Baylin SB and Herman JG: Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 60: 4366-4371, 2000. (Pubitemid 32103613)
34. Debruyne P, Vermeulen S and Mareel M: The role of the E-cadherin/catenin complex in gastrointestinal cancer. Acta Gastroenterol Belg 62: 393-402, 1999. (Pubitemid 30075366)
35. Kanazawa T, Watanabe T, Kazama S, Tada T, Koketsu S and Nagawa H: Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-cadherin expression due to methylation of promoter region. Int J Cancer 102: 225-229 2002. (Pubitemid 35222288)
36. Sparks AB, Morin PJ, Vogelstein B and Kinzler KW: Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58: 1130-1134, 1998. (Pubitemid 28183198)
37. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y and Nakamura Y: AXIN1 mutations in hepatocellular carcinomas and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24: 245-250, 2000. (Pubitemid 30132191)
38. Jubb AM, Bell SM and Quirke P: Methylation and colorectal cancer. J Pathol 195: 111-134, 2001.